Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09WWB
|
|||
| Former ID |
DNCL003245
|
|||
| Drug Name |
MenABCWY
|
|||
| Indication | Meningococcal infection [ICD-11: 1C1C] | Phase 2 | [1] | |
| Company |
Novartis Vaccine & Diagnostics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01992536) Phase 2, Observer-Blind, Placebo-Controlled, Randomized, Multi-Center Extension Study to Evaluate the Safety and Immunogenicity of a Booster Dose of a MenABCWY Vaccine Administered 24 Months Following the Primary Series to Adolescents and Young Adults Who Participated in V102_03. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.